58,000‑Share Option Exercise and 10b5‑1 Sales by CVX (CVX)

Rhea-AI Filing Summary

CVX filing reports Rule 144/Section sales and an exercise transaction by an associated holder. The notice lists a 58,000 share transaction tied to an exercise of stock options on 03/02/2026. The excerpt also lists prior 10b5-1 sales of 35,475 shares on 02/27/2026 for $6,600,563.64 and 41,134 shares on 01/30/2026 for $7,256,037.60.

Insights

Securities Compliance Counsel

Reports show a Rule 144 notice and recent plan-based sales and an option exercise.

The filing lists a 58,000 share transaction described as an exercise of stock options on 03/02/2026, and earlier 10b5-1 plan sales of 35,475 and 41,134 shares on 02/27/2026 and 01/30/2026, respectively, with disclosed gross proceeds.

These entries are procedural notifications under resale rules; cash‑flow treatment and ultimate purchaser details are not in the excerpt. Subsequent filings or broker confirmations could provide settlement details or net proceeds.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	58000	10832080.00	1995385539	03/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/02/2026	Exercise of Stock Options	Issuer			58000	03/02/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for R HEWITT PATE 1400 Smith Street Houston TX 77002	Common	02/27/2026	35475	6600563.64
10b5-1 Sales for R HEWITT PATE 1400 Smith Street Houston TX 77002	Common	01/30/2026	41134	7256037.60

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the CVX Form 144 disclose?

The Form 144 discloses a 58,000-share transaction tied to an exercise of stock options on 03/02/2026, plus prior 10b5-1 sales of 35,475 and 41,134 shares on 02/27/2026 and 01/30/2026.

Who conducted the prior sales listed in the CVX excerpt?

The excerpt identifies the prior sales as 10b5-1 sales for R HEWITT PATE, showing 35,475 shares on 02/27/2026 and 41,134 shares on 01/30/2026, with gross proceeds disclosed for each transaction.

What proceeds are reported for the prior 10b5-1 sales in the CVX filing?

The filing shows gross proceeds of $6,600,563.64 for the 35,475-share sale on 02/27/2026 and $7,256,037.60 for the 41,134-share sale on 01/30/2026 as listed in the excerpt.

Does the Form 144 excerpt state who receives the cash proceeds?

The excerpt lists gross proceeds for the two 10b5-1 sales but does not state who ultimately receives the cash or net proceeds; the filing focuses on shares sold and transaction dates rather than recipient allocation.